Harrow, Inc. (NASDAQ: HROW)
$33.3250
-1.7300 ( -3.82% ) 58.2K
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
Market Data
Open
$33.3250
Previous close
$35.0600
Volume
58.2K
Market cap
$1.25B
Day range
$33.2930 - $36.7090
52 week range
$9.1300 - $59.2300
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Nov 14, 2024 |
10-q | Quarterly Reports | 95 | Nov 14, 2024 |
8-k | 8K-related | 14 | Oct 28, 2024 |
4 | Insider transactions | 1 | Sep 13, 2024 |
8-k | 8K-related | 29 | Sep 09, 2024 |
10-q | Quarterly Reports | 92 | Aug 07, 2024 |
8-k | 8K-related | 18 | Aug 07, 2024 |
8-k | 8K-related | 15 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |